- Denver healthcare providers express concerns about patients losing access to weight loss medications Denver7
- Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats The New York Times
- The GLP-1 drug shortage is over. What’s next for the compounders? Yahoo Finance
- Opinion | Markets Aren’t a Cure-All for Healthcare Costs WSJ
- The future of GLP-1 drugs for obesity treatment: cost, access and more HR Executive
